With successful New Glenn flight, Blue Origin may finally be turning the corner
One of the key questions about Blue Origin is whether it will push toward full reusability with New Glenn. In 2021, Ars first ...
Sectors Up Close: 'Lots of competitors' to Novo Nordisk in healthcare stocks
Obesity drugs - especially Novo Nordic's Ozempic - dominated healthcare headlines in 2024, but Matt Miskin of John Hancock ...
The New York Times11h
New York Times - Top Stories
Stocks Sink as Investors Worry About China’s A.I. Advances A jolt of panic hit technology stocks on Monday, with investors rattled by fears that A.I. advances by Chinese upstarts could threaten ...
CIA says COVID-19 more likely to have come from lab than nature
The Central Intelligence Agency has assessed that the COVID-19 pandemic is more likely to have emerged from a lab than from ...